Abstract
Background
Local ablative therapy of breast cancer represents the next frontier in the minimally invasive breast-conservation treatment. We conducted a phase II trial to evaluate radiofrequency ablation (RFA) of invasive breast carcinomas.
Methods
Consecutive patients from two Mexican Institutions with invasive breast cancers < 4 cm, with no multicentric tumors and no previous chemotherapy were included in this trial. Under ultrasound guidance, the tumor and a 5 mm margin of surrounding breast tissue were ablated with saline-cooled RFA electrode followed by surgical resection. Routine pathologic analysis and viability evaluation with NADPH-diaphorase stain were performed to assess tumor ablation. Procedure-associated morbidity was recorded.
Results
Twenty-five patients were included. Mean patient age was 55.3 years (range 42–89 years). Mean tumor size was 2.08 cm (range 0.9–3.8 cm). Fourteen tumors (56%) were <2 cm. The mean ablation time was 11 minutes using a mean power of 35 W. During ablation, the tumors become progressively echogenic that corresponded with the region of severe RFA injury at pathologic examination. Of the 25 patients treated, NADPH stain showed no evidence of viable malignant cells in 19 patients (76%), with significant difference between tumors <2 cm (complete necrosis in 13 of 14 cases, 92.8%) vs. those >2 cm (complete necrosis 6 of 11 cases, 54.5%) (P < .05). No significant morbidity was recorded.
Conclusions
RFA is a promising minimally invasive treatment of small breast carcinomas, as it can achieve effective cell killing with a low complication rate. Further studies are necessary to optimize the technique and evaluate its future role as local therapy for breast cancer.
Similar content being viewed by others
References
Fisher B. From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century. Eur J Cancer 1999; 35:1963–73
Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15:2345–50
Vrieling C, Collete L, Fourquet A, et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in EORTC “boost vs. no boost” trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 2000; 55:219–32
Singletary SE. Minimally invasive techniques in breast cancer treatment. Semin Oncol 2001; 20:246–50
Kopelman D, Papa M. Magnetic-resonance-guided focused ultrasound surgery for the non-invasive curative ablation of tumors and palliative treatments: a review. Ann Surg Oncol 2007; 14:1540–50
Summer WE, Koniaris LG, Snell SE, et al. Results of 23,810 cases of ductal carcinoma in situ. Ann Surg Oncol 2007; 14:1638–43
McGrahan JP, Griffey SM, Schneider PD, et al. Radiofrequency electrocautery ablation of mammary tissue in swine. Radiology 2000; 217:471–6
Vergara-Fernandez O, Cortes-Gonzalez R, Medina-Franco H. Sentinel node validation in breast cancer with two different techniques. Rev Invest Clin 2004; 56:309–13
Monroe M, Strom EA, Basset LW, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 2002; 52:277–300
Khatri VP, McGahan JP, Ramsamooj R, et al. A phase II trial of image-guided radiofrequency ablation of small invasive breast carcinomas: use of saline-cooled tip electrode. Ann Surg Oncol 2007; 14:1644–52
Park JK, Halperin BD, Kron J, et al. Analysis of body surface area as determinant of impedance during radiofrequency catheter ablation in adults and children. J Electrocardiol 1994; 27:329–32
Wang D, Hulse JE, Walsh EP, et al. Factors influencing impedance during radiofrequency ablation in humans. Chin Med J (Engl) 1995; 108:450–5
Jeffrey SS, Birdwell RR, Ikeda DM, et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg 1999; 134:1064–8
Izzo F, Thomas R, Delrio P, et al. Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer 2001; 92:2036–44
Fornage BD, Sneige N, Ross MI, et al. Small (< or = 2 cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 2004; 231:215–24
Hayashi AH, Silver SF, van der Westhuizen NG, et al. Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am J Surg 2003; 185:429–35
Wood BG, Ramkaransingh JR, Fojo F, et al. Percutaneous tumor ablation with radiofrequency. Cancer 2002; 94:443–51
Marcy PY, Magné N, Castadot P, et al. Ultrasound-guided percutaneous radiofrequency ablation in elderly breast cancer patients: preliminary institutional experience. Br J Radiol 2007; 80:267–73
Oura S, Tamaki T, Hirai I, et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer 2007; 14:48–54
Burak WE Jr, Agnese DM, Povoski SP, et al. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer 2003; 98:1369–76
Dowlatshahi K, Fan M, Gould VE. Stereotactically guided laser therapy of occult breast tumors. Arch Surg 2000; 135: 1345–52
Sabel MS, Kaufman CS, Whitworth P, et al. Cryoablation of early-stage breast cancer: work-in progress report of a multi-institutional trial. Ann Surg Oncol 2004; 11:542–9
Raman SS, Lu DS, Vodopich DJ, et al. Creation of radiofrequency lesions in a porcine model: correlation with sonography, CT, and histopathology. Am J Roentgenol 2000; 175:1253–8
Brookes JA, Redpath TW, Gilbert FJ, et al. Accuracy of T1 measurement in dynamic contrast-enhanced breast MRI using two- and three- dimensional variable flip angle fast low-angle shot. J Magn Reson Imaging 1999; 9:163–71
Tafra L, Cheng Z, Uddo J, et al. Pilot clinical trial of 18F-florodeoxyglucose positron-emission mammography in the surgical management of breast cancer. Am J Surg 2005; 190:628–32
Jan ML, Chuang KS, Chen GW, et al. A three-dimensional registration method for automated fusion of micro PET-CT-SPECT whole body images. Trans Med Imaging 2005; 24:886–93
Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002; 184:383–93
Acknowledgment
This study was supported by grant of Medical Dimegar, Mexico. The authors want to thank Dr. Jorge Zerón-Medina Cuairán for his editorial assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Medina-Franco, H., Soto-Germes, S., Ulloa-Gómez, J.L. et al. Radiofrequency Ablation of Invasive Breast Carcinomas: A Phase II Trial. Ann Surg Oncol 15, 1689–1695 (2008). https://doi.org/10.1245/s10434-008-9875-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-008-9875-4